Alaunos Therapeutics Inc
Biotechnology
Healthcare
TCRT
1.60 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
2.36
52 week high
10.80
high
2.65
52 week low
1.43
low
2.25
growth
-76.42 %
previous Close
2.51
P/E ratio
market cap
2.95 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-1.13 M
0.18 %
eps
0.00 %
0.18 %
eps surprise
0.00 %
net profit margin
-112700000.00 %
282.25 %
operating incoming
-1.15 M
1.37 %
net change in cash
-781.00 K
53.54 %
cash on hand
1.68 M
-31.67 %
cost of revenue
0.00 %
top top